Led by clinicians who understand autism
Our founders bring decades of clinical experience, published research, and a deep personal commitment to helping children with autism reach their full potential.
John Gaitanis, MD
Co-Founder & Chief Medical OfficerDr. Gaitanis is a board-certified pediatric neurologist with extensive clinical research experience in autism spectrum disorders. He served as faculty at academic medical centers where he specialized in neurodevelopmental disorders and biomarker-guided treatments. His work focuses on epilepsy in autism, neuroinflammation, and evidence-based interventions that address underlying biological mechanisms rather
Manifesto
In many children with autism, the body produces autoantibodies (FRAAs) that block special gates called Folate Receptors Alpha (FRα) at the blood-brain barrier. Studies show 70-75% of children with ASD test positive for these antibodies. Even though folate is present in the blood, it cannot get into the brain where it's needed.
Leucovorin (folinic acid) can use a different pathway—the Reduced Folate Carrier (RFC)—to bypass the blocked gates and reach the brain. This is why standard folic acid supplements don't help, but leucovorin might.
Join us and be one of the first 100 Meadow families
Lock in $200/month pricing, work with experienced clinicians who understand autism, and explore leucovorin in a structured, science-aware way. No pressure, no hype—just careful support for your child's folate pathway and your family's journey.
